ALTERNATING NON-CROSS-RESISTANT COMBINATION CHEMOTHERAPY OR MOPP IN STAGE-IV HODGKINS-DISEASE - A REPORT OF 8-YEAR RESULTS

[1] BCVPP CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE - EVIDENCE FOR GREATER DURATION OF COMPLETE REMISSION, GREATER SURVIVAL, AND LESS TOXICITY THAN WITH A MOPP REGIMEN [J]. ANNALS OF INTERNAL MEDICINE, 1984, 101 (04) : 447 - 456

[2] BONADONNA G, 1985, CANCER SURV, V4, P439

[3] 10-YEAR EXPERIENCE WITH CMF-BASED ADJUVANT CHEMOTHERAPY IN RESECTABLE BREAST-CANCER [J]. BREAST CANCER RESEARCH AND TREATMENT, 1985, 5 (02) : 95 - 115

[4] BONADONNA G, 1982, CANCER RES, V42, P4309

[5] EVOLUTION IN THE TREATMENT STRATEGY OF HODGKINS-DISEASE [J]. ADVANCES IN CANCER RESEARCH, 1982, 36 : 257 - 293

[6] BONADONNA G, 1985, SEMIN ONCOL, V12, P23

[7] BONADONNA G, 1975, CANCER, V36, P252, DOI 10.1002/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO

[8] 2-7

[9] ABVD CHEMOTHERAPY IN THE TREATMENT OF HODGKINS-DISEASE [J]. CANCER TREATMENT REVIEWS, 1982, 9 (01) : 21 - 35

[10] CARBONE PP, 1971, CANCER RES, V31, P1860

[1] BCVPP CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE - EVIDENCE FOR GREATER DURATION OF COMPLETE REMISSION, GREATER SURVIVAL, AND LESS TOXICITY THAN WITH A MOPP REGIMEN [J]. ANNALS OF INTERNAL MEDICINE, 1984, 101 (04) : 447 - 456

[2] BONADONNA G, 1985, CANCER SURV, V4, P439

[3] 10-YEAR EXPERIENCE WITH CMF-BASED ADJUVANT CHEMOTHERAPY IN RESECTABLE BREAST-CANCER [J]. BREAST CANCER RESEARCH AND TREATMENT, 1985, 5 (02) : 95 - 115

[4] BONADONNA G, 1982, CANCER RES, V42, P4309

[5] EVOLUTION IN THE TREATMENT STRATEGY OF HODGKINS-DISEASE [J]. ADVANCES IN CANCER RESEARCH, 1982, 36 : 257 - 293

[6] BONADONNA G, 1985, SEMIN ONCOL, V12, P23

[7] BONADONNA G, 1975, CANCER, V36, P252, DOI 10.1002/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO

[8] 2-7

[9] ABVD CHEMOTHERAPY IN THE TREATMENT OF HODGKINS-DISEASE [J]. CANCER TREATMENT REVIEWS, 1982, 9 (01) : 21 - 35

[10] CARBONE PP, 1971, CANCER RES, V31, P1860